In glioblastoma, guanine nucleotide-binding by TG2 promotes glioma cell proliferation, survival, and invasion by interfering with the degradation of the EGF receptor (EGFR), resulting in increased EGFR signaling3,15,32–36 and subsequent cell survival. This evidence concerns the gene TGM2 and central nervous system cancer.